LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells

• Concetta Caglioti,
• Concetta Caglioti,
• Federico Palazzetti,
• Lorenzo Monarca,
• Lorenzo Monarca,
• Raffaele Lobello,
• Maria Rachele Ceccarini,
• Rossana Giulietta Iannitti,
• Roberta Russo,
• Francesco Ragonese,
• Chiara Pennetta,
• Antonella De Luca,
• Michela Codini,
• Bernard Fioretti

Affiliations

Concetta Caglioti

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Concetta Caglioti

Department of Medicine, Perugia Medical School, University of Perugia, Perugia, Italy

Federico Palazzetti

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Lorenzo Monarca

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Lorenzo Monarca

Department of Medicine, Perugia Medical School, University of Perugia, Perugia, Italy

Raffaele Lobello

Relab S.r.l., Genova, Italy

Maria Rachele Ceccarini

Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy

Rossana Giulietta Iannitti

S&R Farmaceutici S.p.A Bastia Umbra, Perugia, Italy

Roberta Russo

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Francesco Ragonese

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Chiara Pennetta

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Antonella De Luca

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy

Michela Codini

Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy

Bernard Fioretti

Department of Chemistry, Biology and Biotechnologies, University of Perugia, Perugia, Italy